Details for New Drug Application (NDA): 087513
✉ Email this page to a colleague
NDA 087513 describes DIPHENHYDRAMINE HYDROCHLORIDE, which is a drug marketed by Alra, Anabolic, Elkins Sinn, Fosun Pharma, Halsey, Heather, Heritage Pharma, Hikma Intl Pharms, Impax Labs, Ivax Sub Teva Pharms, Lannett, Lederle, LNK, Mk Labs, Mutual Pharm, Newtron Pharms, Nexgen Pharma Inc, Perrigo, Pioneer Pharms, Purepac Pharm, Pvt Form, Roxane, Sun Pharm Industries, Superpharm, Teva, Valeant Pharm Intl, Vangard, Watson Labs, Whiteworth Town Plsn, Bundy, Cenci, Kv Pharm, Naska, Pharm Assoc, App Pharms, Bel Mar, Dr Reddys, Gland Pharma Ltd, Hikma, Hospira, Lyphomed, Micro Labs, Mylan Institutional, West-ward Pharms Int, Wyeth Ayerst, Alpharma Us Pharms, Cumberland Swan, Sciegen Pharms Inc, Abraxis Pharm, Fresenius Kabi Usa, and Intl Medication, and is included in seventy-five NDAs. It is available from fourteen suppliers. Additional details are available on the DIPHENHYDRAMINE HYDROCHLORIDE profile page.
The generic ingredient in DIPHENHYDRAMINE HYDROCHLORIDE is diphenhydramine hydrochloride. There are twenty-three drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the diphenhydramine hydrochloride profile page.
The generic ingredient in DIPHENHYDRAMINE HYDROCHLORIDE is diphenhydramine hydrochloride. There are twenty-three drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the diphenhydramine hydrochloride profile page.
Summary for 087513
| Tradename: | DIPHENHYDRAMINE HYDROCHLORIDE |
| Applicant: | Pharm Assoc |
| Ingredient: | diphenhydramine hydrochloride |
| Patents: | 0 |
Pharmacology for NDA: 087513
| Mechanism of Action | Histamine H1 Receptor Antagonists |
Medical Subject Heading (MeSH) Categories for 087513
Suppliers and Packaging for NDA: 087513
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| DIPHENHYDRAMINE HYDROCHLORIDE | diphenhydramine hydrochloride | ELIXIR;ORAL | 087513 | ANDA | PAI Holdings, LLC dba PAI Pharma | 0121-0489 | 0121-0489-00 | 10 TRAY in 1 CASE (0121-0489-00) / 10 CUP, UNIT-DOSE in 1 TRAY / 5 mL in 1 CUP, UNIT-DOSE (0121-0489-05) |
| DIPHENHYDRAMINE HYDROCHLORIDE | diphenhydramine hydrochloride | ELIXIR;ORAL | 087513 | ANDA | PAI Holdings, LLC dba PAI Pharma | 0121-0978 | 0121-0978-00 | 10 TRAY in 1 CASE (0121-0978-00) / 10 CUP, UNIT-DOSE in 1 TRAY / 10 mL in 1 CUP, UNIT-DOSE (0121-0978-10) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | ELIXIR;ORAL | Strength | 12.5MG/5ML | ||||
| Approval Date: | Feb 10, 1982 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
